Ventricular tachycardia causes: Difference between revisions
No edit summary |
|||
(3 intermediate revisions by 3 users not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Ischemic heart disease]] is a common cause of ventricular tachycardia. Other causes of ventricular tachycardia | [[Ischemic heart disease]] is a common cause of [[ventricular tachycardia]]. Other causes of [[ventricular tachycardia]] include [[congenital heart disease]], [[valvular heart disease]], dilated [[non-ischemic cardiomyopathy]], [[sarcoidosis]], [[infiltrative cardiomyopathy]], [[inflammatory cardiomyopathy]], and inherited [[channelopathies]]. In addition, illicit drug use with [[sympathetic activity]] such as [[cocaine]] and [[methamphetamine]], and drugs with [[QT interval prolongation]] effect and also [[electrolyte disturbances]] such as [[hypokalemia]], [[hypomagnesemia]], and [[hypocalcemia]] may cause [[ventricular tachycardia]]. | ||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | ===Life Threatening Causes=== | ||
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. They are mainly due to acute conditions that promote rapid dysfunction of [[automaticity]] and include: | Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. They are mainly due to acute conditions that promote rapid dysfunction of [[automaticity]] and include:<ref name="AjijolaTung2014">{{cite journal|last1=Ajijola|first1=Olujimi A.|last2=Tung|first2=Roderick|last3=Shivkumar|first3=Kalyanam|title=Ventricular tachycardia in ischemic heart disease substrates|journal=Indian Heart Journal|volume=66|year=2014|pages=S24–S34|issn=00194832|doi=10.1016/j.ihj.2013.12.039}}</ref><ref name="Meja LopezMalhotra2019">{{cite journal|last1=Meja Lopez|first1=Eliany|last2=Malhotra|first2=Rohit|title=Ventricular Tachycardia in Structural Heart Disease|journal=Journal of Innovations in Cardiac Rhythm Management|volume=10|issue=8|year=2019|pages=3762–3773|issn=21563977|doi=10.19102/icrm.2019.100801}}</ref><ref name="CoughtrieBehr2017">{{cite journal|last1=Coughtrie|first1=Abigail L|last2=Behr|first2=Elijah R|last3=Layton|first3=Deborah|last4=Marshall|first4=Vanessa|last5=Camm|first5=A John|last6=Shakir|first6=Saad A W|title=Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort|journal=BMJ Open|volume=7|issue=10|year=2017|pages=e016627|issn=2044-6055|doi=10.1136/bmjopen-2017-016627}}</ref><ref name="El-Sherif2001">{{cite journal|last1=El-Sherif|first1=Nabil|title=Mechanism of Ventricular Arrhythmias in the Long QT Syndrome: On Hermeneutics|journal=Journal of Cardiovascular Electrophysiology|volume=12|issue=8|year=2001|pages=973–976|issn=1045-3873|doi=10.1046/j.1540-8167.2001.00973.x}}</ref> | ||
*[[Acute coronary syndrome]] | *[[Acute coronary syndrome]] | ||
*[[Congestive heart failure]] | *[[Congestive heart failure]] | ||
Line 150: | Line 150: | ||
===Causes in Alphabetical Order=== | ===Causes in Alphabetical Order=== | ||
{{ | {{collist|colwidth=20em| | ||
*[[Acid-base disturbances]] | *[[Acid-base disturbances]] | ||
*[[Acidosis]] | *[[Acidosis]] |
Latest revision as of 10:13, 21 May 2021
Ventricular tachycardia Microchapters |
Differentiating Ventricular Tachycardia from other Disorders |
---|
Diagnosis |
Treatment |
Case Studies |
Ventricular tachycardia causes On the Web |
Risk calculators and risk factors for Ventricular tachycardia causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Avirup Guha, M.B.B.S.[2]; Mugilan Poongkunran M.B.B.S [3]
Overview
Ischemic heart disease is a common cause of ventricular tachycardia. Other causes of ventricular tachycardia include congenital heart disease, valvular heart disease, dilated non-ischemic cardiomyopathy, sarcoidosis, infiltrative cardiomyopathy, inflammatory cardiomyopathy, and inherited channelopathies. In addition, illicit drug use with sympathetic activity such as cocaine and methamphetamine, and drugs with QT interval prolongation effect and also electrolyte disturbances such as hypokalemia, hypomagnesemia, and hypocalcemia may cause ventricular tachycardia.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. They are mainly due to acute conditions that promote rapid dysfunction of automaticity and include:[1][2][3][4]
Common Causes
- Acid-base disturbances
- Antiarrhythmics
- Azithromycin
- Cardioversion
- Clarithromycin
- Claritin
- Cocaine
- Congestive heart failure
- Dilated cardiomyopathy
- Erythromycin
- Hypokalemia
- Hypomagnesemia
- Myocarditis
- Obstructive sleep apnea
- Pulmonary artery catheter
- STEMI
- Tricyclic antidepressants
Causes by Organ System
Causes in Alphabetical Order
- Acid-base disturbances
- Acidosis
- Aconitine toxin
- Acute coronary syndrome
- Acute starvation
- Acute stroke
- Addisonian crisis
- Alcoholism
- Alimemazine
- Almokalant
- Amiodarone
- Amitriptyline
- Amphetamines
- Amyloidosis
- Andersen cardiodysrhythmic periodic paralysis
- Anorexia nervosa
- Antiarrhythmics
- Arrhythmogenic right ventricular dysplasia
- Arsenic trioxide
- Arsenicals
- Asenapine
- Astemizole
- AV block
- Azimilide
- Azithromycin
- Bepridil
- Blunt chest trauma
- Bretylium
- Brugada syndrome
- Budipine
- Caffeine
- Cardiac sarcoidosis
- Cardiac transplantation
- Cardiomyopathy
- Cardioversion
- Catecholaminergic polymorphic ventricular tachycardia
- Chagas heart disease
- Channelopathies
- Chloroquine
- Chronic pulmonary artery hypertension
- Cibenzoline
- Cisapride
- Citalopram
- Claritin
- Clomipramine
- Clozapine
- Cocaine
- Congenital Heart Disease
- Congestive heart failure
- COPD
- Crizotinib
- Cushing's syndrome
- Defibrillation
- Desipramine
- Diabetic ketoacidosis
- Dilated cardiomyopathy
- Digitalis
- Diphenhydramine
- Disopyramide
- Dofetilide
- Dolasetron
- Doxepin
- Dronedarone
- Droperidol
- Electrolyte imbalance
- Eribulin mesylate
- Erythromycin
- Fabry disease
- Fluconazole
- Fosphenytoin
- Giant cell myocarditis
- Grepafloxacin
- Halofantrine
- Haloperidol
- Heart surgery
- Heat stroke
- Hyperkalaemia
- Hypertensive heart disease
- Hypertrophic cardiomyopathy
- Hypocalcemia
- Hypoglycaemia
- Hypokalemia
- Hypomagnesemia
- Hypothermia
- Hypothyroidism
- Hypoxia
- Ibutilide
- Idiopathic
- Imipramine
- Indapamide
- Inotropes
- Ischemic heart disease
- Jervell and Lange-Nielsen syndrome
- Ketanserin
- Ketoconazole
- Lidoflazine
- Long QT Syndrome
- Lubeluzole
- Lyme disease
- Major depression
- Methadone
- Methadyl acetate
- Methamphetamine
- Midodrine
- Mitral valve prolapse
- Mizolastine
- Moxifloxacin
- Myocardial Infarction
- Myocarditis
- Myotonic dystrophy
- Myxedema
- Naratriptan
- Nicardipine
- Nilotinib
- Noncompaction cardiomyopathy
- NSTEMI
- Obstructive sleep apnea
- Ondansetron
- Pasireotide
- Pazopanib
- Pentamidine
- Pergolide
- Phenothiazines
- Pimozide
- Piperaquine
- Post-anesthesia
- Prenylamine
- Probucol
- Procainamide
- Propoxyphene
- Pulmonary artery catheter
- QT lengthening
- Quinidine
- Quinine
- Renal failure
- Ranolazine
- Retigabine
- Rheumatoid arthritis
- Right heart catheterisation
- Right ventricular outflow tract tachycardia
- Ritodrine
- Ritonavir
- Romano-Ward syndrome
- Runaway pacemaker syndrome
- Saquinavir
- Sertindole
- Short QT syndrome
- Short QT syndrome type 1
- Short QT syndrome type 2
- Short QT syndrome type 3
- Short QT syndrome type 4
- Short QT syndrome type 5
- Sleep apnea
- Sotalol
- Sparfloxacin
- STEMI
- Sumatriptan
- Sympathomimetic agents
- Systemic lupus erythematosus
- Takotsubo cardiomyopathy
- Tedisamil
- Telithromycin
- Terfenadine
- Terodiline
- Tetrabenazine
- Thioridazine
- Timothy syndrome
- Torsade de pointes
- Unstable angina
- Uremia
- Valvular heart disease
- Vandetanib
- Vemurafenib
- Venlafaxine
- Ventricular aneurysm
- Vernakalant
- Voriconazole
- Vorinostat
- Wolff-Parkinson-White syndrome
- Zero gravity
- Ziprasidone
- Zotepine
- Zuclopenthixol
References
- ↑ Ajijola, Olujimi A.; Tung, Roderick; Shivkumar, Kalyanam (2014). "Ventricular tachycardia in ischemic heart disease substrates". Indian Heart Journal. 66: S24–S34. doi:10.1016/j.ihj.2013.12.039. ISSN 0019-4832.
- ↑ Meja Lopez, Eliany; Malhotra, Rohit (2019). "Ventricular Tachycardia in Structural Heart Disease". Journal of Innovations in Cardiac Rhythm Management. 10 (8): 3762–3773. doi:10.19102/icrm.2019.100801. ISSN 2156-3977.
- ↑ Coughtrie, Abigail L; Behr, Elijah R; Layton, Deborah; Marshall, Vanessa; Camm, A John; Shakir, Saad A W (2017). "Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort". BMJ Open. 7 (10): e016627. doi:10.1136/bmjopen-2017-016627. ISSN 2044-6055.
- ↑ El-Sherif, Nabil (2001). "Mechanism of Ventricular Arrhythmias in the Long QT Syndrome: On Hermeneutics". Journal of Cardiovascular Electrophysiology. 12 (8): 973–976. doi:10.1046/j.1540-8167.2001.00973.x. ISSN 1045-3873.